Natixis Advisors LLC Has $89.54 Million Holdings in McKesson Co. (NYSE:MCK)

Natixis Advisors LLC trimmed its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 3.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 181,102 shares of the company's stock after selling 7,377 shares during the period. Natixis Advisors LLC owned 0.14% of McKesson worth $89,541,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. RFP Financial Group LLC increased its holdings in McKesson by 9.8% during the second quarter. RFP Financial Group LLC now owns 191 shares of the company's stock worth $112,000 after buying an additional 17 shares during the last quarter. Modera Wealth Management LLC increased its holdings in McKesson by 2.2% during the second quarter. Modera Wealth Management LLC now owns 804 shares of the company's stock worth $470,000 after buying an additional 17 shares during the last quarter. Larson Financial Group LLC increased its holdings in McKesson by 1.6% during the second quarter. Larson Financial Group LLC now owns 1,094 shares of the company's stock worth $639,000 after buying an additional 17 shares during the last quarter. First Western Trust Bank increased its holdings in McKesson by 2.0% during the first quarter. First Western Trust Bank now owns 913 shares of the company's stock worth $490,000 after buying an additional 18 shares during the last quarter. Finally, Lester Murray Antman dba SimplyRich increased its holdings in shares of McKesson by 0.4% in the second quarter. Lester Murray Antman dba SimplyRich now owns 5,026 shares of the company's stock valued at $2,935,000 after purchasing an additional 19 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 3,753 shares of the company's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the transaction, the chief executive officer now owns 78,586 shares of the company's stock, valued at $44,094,604.60. This represents a 4.56 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.11% of the company's stock.

McKesson Price Performance

MCK traded down $3.87 on Friday, hitting $606.29. 1,008,159 shares of the stock were exchanged, compared to its average volume of 988,860. McKesson Co. has a 12 month low of $431.35 and a 12 month high of $637.51. The business has a 50-day moving average of $520.01 and a two-hundred day moving average of $554.41. The firm has a market capitalization of $76.96 billion, a price-to-earnings ratio of 31.40, a PEG ratio of 1.31 and a beta of 0.44.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, topping the consensus estimate of $6.88 by $0.19. The firm had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business's quarterly revenue was up 21.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.23 earnings per share. Equities research analysts expect that McKesson Co. will post 32.81 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.47%. The ex-dividend date is Monday, December 2nd. McKesson's payout ratio is 14.71%.

Wall Street Analysts Forecast Growth

MCK has been the topic of several research reports. Evercore ISI upped their price objective on shares of McKesson from $560.00 to $680.00 and gave the company an "outperform" rating in a report on Thursday, November 7th. Robert W. Baird upgraded shares of McKesson from a "neutral" rating to an "outperform" rating and upped their price objective for the company from $531.00 to $688.00 in a report on Thursday, November 7th. Leerink Partners decreased their price objective on shares of McKesson from $665.00 to $630.00 and set an "outperform" rating on the stock in a report on Monday, October 7th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a report on Wednesday, September 25th. Finally, JPMorgan Chase & Co. upped their price objective on shares of McKesson from $656.00 to $661.00 and gave the company an "overweight" rating in a report on Wednesday, August 21st. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $631.57.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.